Idiopathic sudden sensorineural hearing loss (ISSHL), or nerve-related deafness, is the sudden loss of hearing in one or both ears that rapidly occurs within 72 hours or less.
The incidence of ISSHL has been reported to affect approximately 20 people out of every 100,000 people per year. The loss affects women and men just the same.
The severity of ISSHL can be mild or severe, short or long-term – regardless of whether it’s in just one ear or both.
Tinnitus (ringing in the ears) is commonly associated with idiopathic sudden sensorineural hearing loss. Which, take it from this writer, can be quite unsettling!
Treating ISSHL with Hyperbaric Oxygen Therapy!
Developed over 350 years ago, but not readily adopted until the early 1930s when the military tested the use of oxygen as a therapy, hyperbaric chambers were originally used for the purpose of relieving scuba divers of carbon monoxide poisoning or decompression sickness.
Today, increased research has made it possible for hyperbaric oxygen therapy to be used in the treatment of a multitude of FDA and AMA approved illnesses, including idiopathic sudden sensorineural hearing loss.
Hyperbaric oxygen therapy treatment (HBOT) patients are administered 100% medical grade oxygen at increased atmospheric pressures – from 1.3 to 2.5.
This increase in oxygen has been medically proven to effectively speed up the healing process if done within the first three months of your hearing loss.
Patients young and old lie or sit in a hyperbaric chamber (we offer both monoplace and multiplace chambers) that have been specifically designed for therapy.